FDA Takes Steps to Spur OTC Versions of Naloxone

To encourage drug companies to seek approval for over-the-counter versions of naloxone, an emergency treatment for opioid overdose, the Food and Drug Administration has released model consumer-friendly labels for prospective OTC versions of the drug. FDA-approved versions of naloxone currently require a prescription, which “may be a barrier for people who aren’t under the care of a physician or may be ashamed or even fearful of admitting to issues with substance abuse,” said FDA Commissioner Scott Gottlieb, M.D. Before submitting a new drug application or supplement for an OTC drug product, companies must develop a Drug Facts Label and conduct studies to show that consumers can understand how to use the product without the supervision of a healthcare professional.

Visit Us

North Carolina Healthcare Association

2400 Weston Parkway
Cary, NC 27513

Main: 919-677-2400
Fax: 919-677-4200

Contact Us